EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Human Nasal Inferior Turbinate-Derived Neural Stem Cells Improve the Niche of Substantia Nigra Par Compacta in a Parkinson’s Disease Model by Modulating Hippo Signaling

Junwon Choi, Sun Wha Park, Hyunji Lee, Do Hyun Kim, Sung Won Kim iD

Tissue Engineering and Regenerative Medicine · 2024-07 · 21 (5) · 737-748

DOI: 10.1007/s13770-024-00635-3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Tissue Engineering and Regenerative Medicine, online erschienen am 10.04.2024. Verfasst von Junwon Choi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic…. Hauptthemen laut MEDLINE: Neural Stem Cells, Hippo Signaling Pathway, Signal Transduction, Protein Serine-Threonine Kinases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and ICT, South Korea, Korean Fund for Regenerative Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson’s disease (PD) is one of the most prevalent neurodegenerative diseases, following Alzheimer’s disease. The onset of PD is characterized by the loss of dopaminergic neurons in the substantia nigra. Stem cell therapy has great potential for the treatment of neurodegenerative diseases, and human nasal turbinate-derived stem cells (hNTSCs) have been found to share some characteristics with mesenchymal stem cells. Although the Hippo signaling pathway was originally thought to regulate cell size in organs, recent studies have shown that it can also control inflammation in neural cells.

Methods

Dopaminergic neuron-like cells were differentiated from SH-SY5Y cells (DA-Like cells) and treated with 1-Methyl-4-phenylpyridinium iodide to stimulate Reactive oxidative species (ROS) production. A transwell assay was conducted to validate the effect of hNTSCs on the Hippo pathway. We generated an MPTP-induced PD mouse model and transplanted hNTSCs into the substantia nigra of PD mice via stereotaxic surgery. After five weeks of behavioral testing, the brain samples were validated by immunoblotting and immunostaining to confirm the niche control of hNTSCs.

Results

In-vitro experiments showed that hNTSCs significantly increased cell survival and exerted anti-inflammatory effects by controlling ROS-mediated ER stress and hippocampal signaling pathway factors . Similarly, the in-vivo experiments demonstrated an increase in anti-inflammatory effects and cell survival rate. After transplantation of hNTSCs, the PD mouse model showed improved mobility and relief from PD symptoms. Conclusion: hNTSCs improved the survival rate of dopaminergic neurons by manipulating the hippocampal pathway through Yes-associated protein (YAP)/transcriptional coactivator with a PDZ-binding motif (TAZ) by reducing inflammatory cytokines. In this study, we found that controlling the niche of hNTSCs had a therapeutic effect on PD lesions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neural Stem CellsHippo Signaling PathwaySignal TransductionProtein Serine-Threonine KinasesParkinson DiseaseDisease Models, AnimalTurbinatesHumansAnimalsMiceDopaminergic NeuronsPars CompactaMaleMice, Inbred C57BLSubstantia NigraReactive Oxygen SpeciesCell Differentiation

Stichwörter der Autor:innen

Cell-based therapyHuman nasal turbinate derived stem cellsNiche controlParkinson’s diseaseRegenerative medicine

Substanzen

Protein Serine-Threonine KinasesReactive Oxygen Species

Autor:innen und Institutionen

  • Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
  • Postech-Catholic Biomedical Engineering Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Otolaryngology-Head and Neck Surgery, College of Medicine, Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea. kswent@catholic.ac.kr.
  • Postech-Catholic Biomedical Engineering Institute, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea. kswent@catholic.ac.kr.

ORCID-Profile: Sung Won Kim

Förderung

  • Ministry of Science and ICT, South Korea
  • Korean Fund for Regenerative Medicine

Zitieren

APA

Choi, J., Park, S. W., Lee, H., Kim, D. H., & Kim, S. W. (2024). Human Nasal Inferior Turbinate-Derived Neural Stem Cells Improve the Niche of Substantia Nigra Par Compacta in a Parkinson’s Disease Model by Modulating Hippo Signaling. Tissue Engineering and Regenerative Medicine, 21(5), 737-748. https://doi.org/10.1007/s13770-024-00635-3

Vancouver

Choi J, Park SW, Lee H, Kim DH, Kim SW. Human Nasal Inferior Turbinate-Derived Neural Stem Cells Improve the Niche of Substantia Nigra Par Compacta in a Parkinson’s Disease Model by Modulating Hippo Signaling. Tissue Engineering and Regenerative Medicine. 2024;21(5):737-748. doi:10.1007/s13770-024-00635-3

BibTeX
@article{Choi2024,
  author = {Choi, Junwon and Park, Sun Wha and Lee, Hyunji and Kim, Do Hyun and Kim, Sung Won},
  title = {Human Nasal Inferior Turbinate-Derived Neural Stem Cells Improve the Niche of Substantia Nigra Par Compacta in a Parkinson’s Disease Model by Modulating Hippo Signaling},
  journal = {Tissue Engineering and Regenerative Medicine},
  year = {2024},
  volume = {21},
  number = {5},
  pages = {737--748},
  doi = {10.1007/s13770-024-00635-3}
}
Kostenlos starten →